Back to Cardiology
Cardiologyv2.0Evidence-Based

GRACE ACS Risk and Mortality Calculator

Estimates admission to 6-month mortality risk for patients with acute coronary syndrome. Uses 8 clinical variables to provide risk stratification and guide treatment decisions in both ST-elevation and non-ST-elevation ACS.

Clinical Input Parameters

years
Range: 20 — 100 years
bpm
Range: 30 — 250 bpm
mmHg
Range: 50 — 300 mmHg
mg/dL
Range: 0.3 — 15 mg/dL
Clinical Assessment
Awaiting Parameters
grace score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The GRACE ACS Risk and Mortality Calculator is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

GRACE Score = Age points + Heart Rate points + Systolic BP points + Creatinine points + Killip Class points + (28 × ST deviation) + (14 × Elevated biomarkers) + (39 × Cardiac arrest)

Clinical Pearls & Practice Notes

  • Validated in over 43,000 patients from 94 hospitals worldwide
  • Provides both in-hospital and 6-month mortality estimates
  • Recommended by NICE guidelines for ACS risk stratification
  • Applicable to both STEMI and NSTEMI patients
  • Score should be used in conjunction with clinical judgment
  • Higher scores indicate increased need for intensive monitoring and invasive interventions
  • Age, heart rate, systolic BP, and creatinine use continuous scoring algorithms
  • Consider patient comorbidities and overall clinical picture when interpreting results

Evidence & Literature Citations

  1. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333(7578):1091. doi: 10.1136/bmj.38985.646481.55.
  2. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53. doi: 10.1001/archinte.163.19.2345.
  3. Abu-Assi E, Gracía-Acuña JM, Peña-Gil C, González-Juanatey JR. Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2010;63(6):640-8. doi: 10.1016/s1885-5857(10)70139-4.
  4. NICE Clinical Guideline 167. Myocardial infarction with ST-segment elevation: acute management. National Institute for Health and Care Excellence; 2013.

Score Interpretation Ranges

Very Low Risk0 – 87 pts

Excellent prognosis

Low Risk88 – 128 pts

Good prognosis

Intermediate Risk129 – 149 pts

Moderate prognosis

High Risk150 – 173 pts

Poor prognosis

Very High Risk174 – 284 pts

Very poor prognosis

Extremely High Risk285 – 400 pts

Critical prognosis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.